Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
More from Breast ImplantsMore posts in Breast Implants »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Current status of breast implant products in Australia
- DSVG 04 – Breast Implants – Guidance on the vigilance system for CE-marked medical devices
More from Draft GuidanceMore posts in Draft Guidance »
- US draft guidance – Soft (Hydrophilic) Daily Wear Contact Lenses – Performance Criteria for Safety and Performance Based Pathway
- US FDA Update on Laparoscopic Power Morcellators – actions and draft guidance
- US FDA Draft Guidance – FDA Issues Draft Guidance on Arthroscopy Pump Tubing Sets
- US FDA Draft Guidance – Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions
- TGA – IVD companion diagnostics – Guidance on proposed regulatory requirements
More from United States Food and Drug Administration - US FDAMore posts in United States Food and Drug Administration - US FDA »
- EU – Team-NB Position Paper on Documentation Requirements for Drug Device Combination Products Falling in the Scope of Article 117 of MDR 2017/745.
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- US – Ventilator Supply Mitigation Strategies – Letter to Health Care Providers
- US – Update on the Ethylene Oxide Sterilization Master File Pilot Program
- US – FDA Engagement to Mitigate Potential Shortage of Personal Protective Equipment (PPE)
Be First to Comment